Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
30 April 2024 - P3982
Successful use of prolonged oral nirmatrelvir/ritonavir in an immunocompromised host with persistent SARS-CoV-2 viraemia and severe pneumonitis
Jessica Taylor
28 April 2024 - E0445
Safety and pharmacokinetics of single and multiple ascending doses of ALG-097558, a pan-coronavirus protease inhibitor, in healthy volunteers
Denisa Wilkes, Christina Yeung, Karen Dhillon, Kha Le, Stanley Wang, Chris Burnett, Jen Rito, Kusum Gupta, Doug Clark, Andreas Jekle, Sandra Chang, Naqvi Mohammed, Qiaoying Li, Meenakshi Venkatraman, Leonid Beigelman, Lawrence Blatt, Tse-I Lin, Sushmita Chanda, Matthew Mcclure
28 April 2024 - E0442
Comparative effectiveness of combination therapy with nirmatrelvir-ritonavir and remdesivir vs monotherapy with remdesivir or nirmatrelvir-ritonavir in hospitalised COVID-19 patients: a target trial emulation study
Ming Hong Choi, Eric Yuk Fai Wan, Ian Chi Kei Wong, Esther Wai Yin Chan, Wing Ming Chu, Anthony Raymond Tam, Kwok Yung Yuen, Ivan Fan Ngai Hung
28 April 2024 - E0441
Cost-effectiveness analysis of nirmatrelvir/ritonavir for high-risk individuals with COVID-19: a modelling study
Emma Birnie, Magda Vergouwe, Brent Appelman, Jason Jacob Biemond, Jarom Heijmans, Godelieve J. De Bree, Brooke E. Nichols, Willem Joost Wiersinga, Stephanie Popping
27 April 2024 - P0580
Nirmatrelvir/ritonavir or remdesivir for COVID-19 in patients with B-cell malignancies and plasma cell dyscrasias
Dimitra Vlachopoulou, Maria Arapaki, Pantazis-Michael Voutsinas, Dimitris Basoulis, Elpida Mastrogianni, Panagiotis Diamantopoulos, Vasiliki Georgakopoulou, Eleni Siavou, Maria Dimou, Aikaterini Bitsani, Fotios Panitsas, Marina Siakantaris, Theodoros Vassilakopoulos, Maria Angelopoulou, Nikolaos Sipsas, Amalia Anastasopoulou
27 April 2024 - P0340
Cost-effectiveness of oral nirmatrelvir/ritonavir in patients at high risk for progression to severe COVID-19 in the United States
Josh Carlson, Volker Foos, Adam Kasle, Tendai Mugwagwa, Florin Draica, Timothy Wiemken, Jennifer Nguyen, Ashley Cha-Silva, Kristen Migliaccio-Walle, Mendwas Dzingina
27 April 2024 - P0572
Nirmatrelvir/ritonavir in the management of COVID-19: a retrospective study in a highly vaccinated population
Maria João Gonçalves, Clara Batista, Constança Azeredo, Frederico Duarte, Sara Araújo, Eduarda Pena, Mário Guimarães, Ricardo Correia Abreu, Sofia Jordão
27 April 2024 - P0325
Drug interactions with nirmatrelvir/ritonavir in hospitalised patients: prevalence, severity and management strategies
Sohair Swaid, Mirit Hershman-Sarafov, Nizar Jiries, Alona Paz,
18 April 2023 - O1119
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
Jon Salmanton-García, Francesco Marchesi, Maria Gomes Da Silva, Francesca Farina, Julio Dávila-Valls, Sonia Martín-Pérez, Yavuz M. Bilgin, Raquel Nunes Rodrigues, Laman Rahimli, Livio Pagano, Oliver A. Cornely
18 April 2023 - LB003
Detecting positivity rebound of SARS-CoV-2 following treatment with nirmatrelvir-ritonavir and molnupiravir in the community
Katie Harman, Alessandra Løchen, Fernando Capelastegui, Omaer Syed, Meera Chand, Susan Hopkins, Colin S Brown, Alicia Demirjian, Sakib Rokadiya, Bethan Mcdonald, Gavin Dabrera
17 April 2023 - P2624
Development and evaluation of an interaction tool to prevent severe drug-drug interactions with nirmatrelvir/ritonavir
Greet Van De Sijpe, Charlotte Quintens, Paul De Munter, Isabel Spriet
17 April 2023 - P2617
Population pharmacokinetics and pharmacodynamics of favipiravir in combination with lopinavir-ritonavir in patients with COVID-19
Akosua Agyeman, Li-An K. Brown, Jose A. Guerra-Assuncao, Judy Breuer, David M. Lowe, Joseph F. Standing
17 April 2023 - P2517
Combination treatment of persistent COVID-19 in immunocompromised patients with remdesivir, nirmaltrevir/ritonavir and tixegavimab/cilgavimab
Tal Brosh-Nissimov, Nir Maaravi, Daniel Leshin, Yonatan Edel, Sharon Ben Baruch, Segman Yafit, Amos Cahn
17 April 2023 - P2505
Efficacy, tolerability and prescribing choice of antivirals molecules molnupiravir, remdesivir and nirmatrelvir/ritonavir: a real-world comparison in the first six months of use
Silvia Garattini, Carolina Bortignon, Eeva Tortellini, Anna Carraro, Daniela Di Trento, Andrea Gasperin, Alessandra Grimaldi, Tiziana Tieghi, Valeria Belvisi, Raffaella Marocco, Gabriella Bonanni, Danilo Alunni Fegatelli, Alessandra Spagnoli, Ombretta D'Onofrio, Cosmo Del Borgo, Claudio Maria Mastroianni, Miriam Lichtner
16 April 2023 - O0428
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe: a matched-paired analysis from the EPICOVIDEHA registry
Jon Salmanton-García, Francesco Marchesi, Barbora Weinbergerová, Caterina Buquicchio, Nataša Čolović, Jens Van Praet, Philipp Koehler, Iker Falces-Romero, Francesca Farina, Federico Itri, Alessandra Romano, Livio Pagano, Oliver A. Cornely
23 April 2022 - B0006
Camostat mesylate versus lopinavir/ritonavir in hospitalised patients with COVID-19: results from a randomised, controlled, open-label, platform trial (ACOVACT)
Mario Karolyi, Erich Pawelka, Sara Omid, Franz Koenig, Victoria Kauer, Benedikt Rumpf, Wolfgang Hoepler, Avelino Kuran, Hermann Laferl, Tamara Seitz, Marianna Traugott, Vincent Rathkolb, Martin Mueller, Agnes Abrahamowicz, Christian Schoergenhofer, Manfred Hecking, Alice Assinger, Christoph Wenisch, Markus Zeitlinger, Bernd Jilma, Alexander Zoufaly
23 April 2022 - B0007
Favipiravir, lopinavir-ritonavir or combination therapy (FLARE): a randomised, double blind, 2x2 factorial placebo-controlled trial of early antiviral therapy in COVID-19
David Lowe, Li-An Brown, Kashfia Chowdhury, Stephanie Davey, Philip Yee, Felicia Ikeji, Amalia Ndoutoumou, Divya Shah, Alexander Lennon, Abhulya Rai, Akosua Agyeman, Anna Checkley, Nicola Longley, Hakim-Moulay Dehbi, Nick Freemantle, Judith Breuer, Joseph Standing
09 July 2021 - 738
Pharmacokinetics of lopinavir/ritonavir in hospitalised patients with COVID-19 not requiring critical care
Alasdair Macgowan, A. Macgowan, F. Hamilton, M. Bayliss, L. Read, M. Attwood, A. Noel, M. Albur, S. Grier, A. Morley, D. Arnold, N. Maskell
23 September 2020 - P473
Did Darunavir /ritonavir, in association with standard of care, reduce the duration of hospitalization in patients with moderate COVID 19?
Mihaela Lupse, M. Lupse, V. Briciu, M. Muntean, C. Cismaru, A. Radulescu, L. Herbel
14 April 2019 - P0702
Efficacy and safety of darunavir-ritonavir 1200/100mg once daily for the treatment of HIV-1 Infection: DARONCE study
Christianne Takeda, Melissa Medeiros, Priscyla Araripe, Karina Noroes, Larissa Amorim, Yandra Mirelle Alves, Jose Edvar Di Castro Junior, Antonio Erisvaldo Ponte Filho, Leticia Cristino, Juliana Oliveira, Kilmer Castelo Branco, Gustavo Igor Rodrigues, Luan Victor Lima
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.